for the Annual Meeting of Stockholders
PHONE:
Call toll
free
1-866-752-8683
FAX:
Send this
card to
202-521-3464
https://www.iproxydirect.com/atnf
and follow the on-screen instructions.
EMAIL:
proxy@iproxydirect.com
Include your Control ID in your email.
until 11:59 pm Pacific time July 5, 2023.
1. To elect four directors to the Board of Directors (the “Board”) each to serve until their respective successors have been elected and qualified, or until such directors’ resignation or removal;
2. Approval of the adoption of the First Amendment to the 180 Life Sciences Corp. 2022 Omnibus Incentive Plan;
3. Advisory vote to approve named executive officer compensation, as described in the 180 Life Sciences Corp. Proxy Statement;
4. Advisory Vote on the frequency of future advisory votes to approve named executive officer compensation;
5. Ratification of the appointment of Marcum LLP, as the Company’s independent auditors for the fiscal year ending December 31, 2023;
6. Approval of an Amendment to the Company’s Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company; and
7. to transact such other business as may properly come before the annual meeting.
Pursuant to Securities and Exchange Commission rules, you are receiving this Notice that the proxy materials for the Annual Meeting are available on the Internet. Follow the instructions above to view the materials and vote or request printed copies.
The board of directors has fixed the close of business on May 11, 2023 as the record date for the determination of stockholders entitled to receive notice of the Annual Meeting and to vote the shares of our common stock and preferred stock, they held on that date at the meeting or any postponement or adjournment of the meeting.